Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Risk calculators for hepatocellular carcinoma in patients affected with chronic hepatitis B in Asia.

Yang HI, Lee MH, Liu J, Chen CJ.

World J Gastroenterol. 2014 May 28;20(20):6244-51. doi: 10.3748/wjg.v20.i20.6244. Review.

2.

What can we learn from hepatitis B virus clinical cohorts?

Lin CL, Tseng TC, Kao JH.

Liver Int. 2015 Jan;35 Suppl 1:91-9. doi: 10.1111/liv.12716. Review.

PMID:
25529093
3.

Risk stratification for hepatitis B virus related hepatocellular carcinoma.

Lin CL, Kao JH.

J Gastroenterol Hepatol. 2013 Jan;28(1):10-7. doi: 10.1111/jgh.12010.

PMID:
23094699
4.

Liver stiffness-based optimization of hepatocellular carcinoma risk score in patients with chronic hepatitis B.

Wong GL, Chan HL, Wong CK, Leung C, Chan CY, Ho PP, Chung VC, Chan ZC, Tse YK, Chim AM, Lau TK, Wong VW.

J Hepatol. 2014 Feb;60(2):339-45. doi: 10.1016/j.jhep.2013.09.029.

PMID:
24128413
5.

Natural history of chronic hepatitis B REVEALed.

Chen CJ, Yang HI.

J Gastroenterol Hepatol. 2011 Apr;26(4):628-38. doi: 10.1111/j.1440-1746.2011.06695.x. Review.

PMID:
21323729
6.

Occult hepatitis B virus and hepatocellular carcinoma.

Pollicino T, Saitta C.

World J Gastroenterol. 2014 May 28;20(20):5951-61. doi: 10.3748/wjg.v20.i20.5951. Review.

7.

Natural history of chronic hepatitis B: what exactly has REVEAL revealed?

Iloeje UH, Yang HI, Chen CJ.

Liver Int. 2012 Oct;32(9):1333-41. doi: 10.1111/j.1478-3231.2012.02805.x. Review.

PMID:
22510145
8.

Prediction models of long-term cirrhosis and hepatocellular carcinoma risk in chronic hepatitis B patients: risk scores integrating host and virus profiles.

Lee MH, Yang HI, Liu J, Batrla-Utermann R, Jen CL, Iloeje UH, Lu SN, You SL, Wang LY, Chen CJ; R.E.V.E.A.L.-HBV Study Group..

Hepatology. 2013 Aug;58(2):546-54. doi: 10.1002/hep.26385.

PMID:
23504622
9.

Risk stratification of HBV infection in Asia-Pacific region.

Kao JH.

Clin Mol Hepatol. 2014 Sep;20(3):223-7. doi: 10.3350/cmh.2014.20.3.223. Review.

10.

Nomograms for risk of hepatocellular carcinoma in patients with chronic hepatitis B virus infection.

Yang HI, Sherman M, Su J, Chen PJ, Liaw YF, Iloeje UH, Chen CJ.

J Clin Oncol. 2010 May 10;28(14):2437-44. doi: 10.1200/JCO.2009.27.4456.

PMID:
20368541
11.

Prevention of hepatocellular carcinoma in the Asia-Pacific region: consensus statements.

Asia-Pacific Working Party on Prevention of Hepatocellular Carcinoma..

J Gastroenterol Hepatol. 2010 Apr;25(4):657-63. doi: 10.1111/j.1440-1746.2009.06167.x.

PMID:
20492323
13.

[The discrepancy of HBsAg titre and HBV DNA in patients with chronic hepatitis B, HBV-related liver cirrhosis and hepatocellular carcinoma].

Pei YZ, Han T, Ma XY, Li Y, Xing J, Song ZL.

Zhonghua Gan Zang Bing Za Zhi. 2011 Oct;19(10):743-6. doi: 10.3760/cma.j.issn.1007-3418.2011.10.006. Chinese.

PMID:
22409845
14.

Prevention of hepatocellular carcinoma in hepatitis B virus infection.

Lim SG, Mohammed R, Yuen MF, Kao JH.

J Gastroenterol Hepatol. 2009 Aug;24(8):1352-7. doi: 10.1111/j.1440-1746.2009.05985.x. Review.

PMID:
19702903
15.

Risk factors for hepatocellular carcinoma in patients with drug-resistant chronic hepatitis B.

Jun CH, Hong HJ, Chung MW, Park SY, Cho SB, Park CH, Joo YE, Kim HS, Choi SK, Rew JS.

World J Gastroenterol. 2013 Oct 28;19(40):6834-41. doi: 10.3748/wjg.v19.i40.6834.

16.

Risk prediction of hepatitis B virus-related hepatocellular carcinoma in the era of antiviral therapy.

Wong GL, Wong VW.

World J Gastroenterol. 2013 Oct 21;19(39):6515-22. doi: 10.3748/wjg.v19.i39.6515. Review.

17.

Perioperative antiviral therapy for chronic hepatitis B-related hepatocellular carcinoma.

Wei Q, Xu X, Ling Q, Zhou B, Zheng SS.

Hepatobiliary Pancreat Dis Int. 2013 Jun;12(3):251-5. Review.

18.

HBsAg Seroclearance in chronic hepatitis B in Asian patients: replicative level and risk of hepatocellular carcinoma.

Yuen MF, Wong DK, Fung J, Ip P, But D, Hung I, Lau K, Yuen JC, Lai CL.

Gastroenterology. 2008 Oct;135(4):1192-9. doi: 10.1053/j.gastro.2008.07.008.

PMID:
18722377
19.

Chronic hepatitis B virus infection in Asian countries.

Merican I, Guan R, Amarapuka D, Alexander MJ, Chutaputti A, Chien RN, Hasnian SS, Leung N, Lesmana L, Phiet PH, Sjalfoellah Noer HM, Sollano J, Sun HS, Xu DZ.

J Gastroenterol Hepatol. 2000 Dec;15(12):1356-61. Review.

PMID:
11197043
20.

Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B.

Yuen MF, Tanaka Y, Fong DY, Fung J, Wong DK, Yuen JC, But DY, Chan AO, Wong BC, Mizokami M, Lai CL.

J Hepatol. 2009 Jan;50(1):80-8. doi: 10.1016/j.jhep.2008.07.023.

PMID:
18977053
Items per page

Supplemental Content

Support Center